Document is current
Any future updates will be listed below
-
Authors
Parhizkar, Samira https://orcid.org/0000-0001-5807-190X
Bao, Xin
Chen, Wei
Rensing, Nicholas
Chen, Yun
Kipnis, Michal
Song, Sihui
Gent, Grace
Tycksen, Eric https://orcid.org/0000-0001-6362-0141
Manis, Melissa https://orcid.org/0000-0001-7912-2016
Lee, Choonghee
Serrano, Javier Remolina
Bosch, Megan E.
Franke, Emily
Yuede, Carla M. https://orcid.org/0000-0001-6362-4767
Landsness, Eric C.
Wong, Michael
Holtzman, David M. https://orcid.org/0000-0002-3400-0856
-
Funding
Funding for this research was provided by:
Foundation for the National Institutes of Health (P01NS074969, RF1NS090934, RF1AG061776)
JPB Foundation
Alzheimer's Association (AARF-21-850865)
- License Information
-
More Information
Article History
Received: 23 November 2022
Accepted: 2 April 2025
First Online: 27 May 2025
Competing interests
: D.M.H. is an inventor on a patent licensed by Washington University to C2N Diagnostics on the therapeutic use of anti-tau antibodies; cofounded and is on the scientific advisory board of C2N Diagnostics; is on the scientific advisory board of Denali, Genentech, Cajal Neuroscience and Switch Therapeutics and consults for Pfizer and Roche. The other authors declare no competing interests.
